← Leaderboards
Christopher J Barnum
Inmune Bio, Inc.
$1,950,421
Attributed
$1,950,421
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2020–21$2M$1.5M$1M$500K$0
'20
'21
Funding mix
By agency
NIH$1,950,421 · 1
By mechanism
R44$1,950,421 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Chronic”
- Jeffrey Reich · Sparian Biosciences, Inc.$21,671,295
- Priyamvada Acharya · Duke University$20,941,151
- Dale Sandler · Social And Scientific Systems, Inc.$18,360,118
- Steven Schachter · Massachusetts General Hospital$18,327,380
- Suparna Goswami · Univ Of North Carolina Chapel Hill$16,919,767
- Abraham Aizer Brody · New York University School Of Medicine$15,928,507
Research focus
ChronicAlzheimer&AposAffectAcute-Phase ProteinsAntidepressive AgentsAnti-Inflammatory AgentsAnti-Tumor Necrosis Factor TherapyAnhedoniaAutoimmune DiseasesAnimal ModelBaseBehavioral PhenotypingBiological AvailabilityBiological MarkersBiologyBiomarker-DrivenBloodBrainBrain CircuitryBrain RegionBurden Of IllnessCancer PatientCellsComplex
Grant awards (2)
Effects of the Next Generation TNF Inhibitor (XPro1595) on Inflammation-related Deficits in Reward Circuitry and Motivation in Depression$1,210,682
R44 · FY2021 · MH · contact PI
Effects of the Next Generation TNF Inhibitor (XPro1595) on Inflammation-related Deficits in Reward Circuitry and Motivation in Depression$739,739
R44 · FY2020 · MH · contact PI